Hibiscus Capital Management
Startup rounds since 2016 with a Hibiscus Capital Management investor on the board, and the firm's own fund filings.
Raises
8
since 2016
Unannounced
0
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- Sendero Biotechnology, Inc.$7.34M
- Contraline, Inc.$7.23M
- AsclepiX Therapeutics, Inc.$10M
- AsclepiX Therapeutics, Inc.$7.74M
- Velicept Therapeutics, Inc.$15.5M
- Velicept Therapeutics, Inc.$18.4M
- TECTURA Corp$14.8K
- TECTURA Corp$10.5M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2023 | 1 | — |
| 2022 | 1 | — |
| 2020 | 1 | — |
| 2019 | 1 | — |
| 2018 | 1 | — |
| 2017 | 1 | — |
| 2016 | 2 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Hibiscus Capital Management Fund II LP | 22 Dec 2023 | $150M | $6.92M |
Listed because a Hibiscus Capital Management fund's filing names a director of each company. A name match is not a verified identity.